This item requires a subscription to Diabetes Care.
Cover
Full Text (PDF)
Cardiovascular and Metabolic Risk:
  • Russell Scott,
  • Richard O'Brien,
  • Greg Fulcher,
  • Chris Pardy,
  • Michael d'Emden,
  • Dana Tse,
  • Marja-Riitta Taskinen,
  • Christian Ehnholm,
  • and Anthony Keech
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Diabetes Care March 2009 32:493-498; published ahead of print November 4, 2008, doi:10.2337/dc08-1543
To view this item, select one of the options below:

This Article

  1. Published online before print November 4, 2008, doi: 10.2337/dc08-1543 Diabetes Care March 2009 vol. 32 no. 3 493-498
  1. Show PDF in full window
  2. AbstractFree
  3. Full Text
  4. » Full Text (PDF)
  5. Online-Only Appendix

Current Issue

  1. February 2010, 33 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care